Literature DB >> 26782008

Does Using Complementary Health Insurance Affect Hospital Length of Stay? Evidence from Acute Coronary Syndrome Patients.

Masoud Arefnezhad1, Vahid Yazdi Feyzabadi2,3, Enayatollah Homaie Rad2, Zahra Sepehri1, Saeideh Pourmand1, Mohadeseh Rava1.   

Abstract

BACKGROUND: Length of stay (LOS) is used as an indicator to show the efficacy of hospitals. An increase in hospitalized days is not cost effective and decreases the efficacy of hospitals. Using insurance has some side effects. One of these side effects is increasing the LOS. In this study we attempt to discover the effects of complementary health insurance (CHI) on LOS in patients with acute coronary syndrome (ACS).
METHODS: In this cross-sectional study, 260 patients were surveyed. By using Poisson regression, the effects of using complementary health insurance on LOS were examined. The effects of confounders were also controlled in the model.
RESULTS: The results of this study demonstrated that the relationship between use of CHI and LOS is direct. In addition, an increase in age and income also increases the LOS. The average LOS was 4.13 days, while it was 5.31 for CHI users, and 3.81 for CHI nonusers.
CONCLUSION: Government budget is restricted and ACS treatments are costly. Decreasing LOS in ACS patients can help to spend the budget more effectively.

Entities:  

Keywords:  Hospital length of stay; Iran; complementary health insurance; poisson regression

Mesh:

Year:  2016        PMID: 26782008     DOI: 10.1080/21548331.2016.1143781

Source DB:  PubMed          Journal:  Hosp Pract (1995)        ISSN: 2154-8331


  2 in total

1.  Complementary health insurance, out- of- pocket expenditures, and health services utilization: A population- based survey.

Authors:  Enayatollah Homaie Rad; Zahra Kavosi; Mohammad Taghi Moghadamnia; Masoud Arefnezhad; Masoumeh Arefnezhad; Banfashe Felezi Nasiri
Journal:  Med J Islam Repub Iran       Date:  2017-09-09

2.  Understanding variations and influencing factors on length of stay for T2DM patients based on a multilevel model.

Authors:  Wen Liu; Jingcheng Shi; Simin He; Xi Luo; Weijun Zhong; Fang Yang
Journal:  PLoS One       Date:  2021-03-12       Impact factor: 3.240

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.